Elanco Animal Health to Showcase Innovations at UBS Global Healthcare Conference

Elanco Animal Health to Attend UBS Global Healthcare Conference

Elanco Animal Health Incorporated (NYSE: ELAN) has announced its participation in the prestigious UBS Global Healthcare Conference, set for November 9, 2026. The event presents a valuable opportunity for the company to connect with industry stakeholders and share insights into its innovations in animal health.

Bob VanHimbergen, Elanco's executive vice president and CFO, alongside Bobby Modi, the executive vice president overseeing U.S. Pet Health and Global Digital Transformation, will be part of a fireside chat scheduled for that day at 1:15 PM EST. This engaging dialogue is expected to cover a range of topics including the recent advancements in animal health technology and strategies for addressing emerging issues within the sector.

The UBS Global Healthcare Conference is renowned for bringing together prominent leaders, innovators, and investors from the healthcare field, making it an ideal platform for Elanco to showcase its commitment to improving animal health and welfare. Participants at the conference will gain insights into how Elanco continues to pioneer products and services aimed at preventing and treating diseases affecting both farm animals and pets, with an emphasis on creating value for farmers, pet owners, veterinarians, and the broader society.

Elanco, with its strong heritage of over 70 years in animal health, is dedicated to breaking new ground in the industry. The company is guided by its vision encapsulated in the phrase, "Food and Companionship Enriching Life." This mission underscores Elanco's dedication to not only advancing animal health but also supporting sustainable agricultural practices that ultimately benefit humanity.

In preparation for the conference, interested parties can access a live audio webcast via the 'Events and Presentations' section of Elanco’s investor website. A recording will also be available for a limited time after the event, ensuring that those unable to attend live can still benefit from the insights shared during the discussion.

The presence of Elanco at such a high-profile event signals the company's strategic focus on innovation and high-level engagement within the healthcare landscape. As trends in animal health continue to evolve — influenced by technological advancements and changing consumer preferences — Elanco remains at the forefront, committed to delivering cutting-edge solutions for the challenges faced in the animal health arena.

For more information about Elanco Animal Health and to stay updated on their latest initiatives, visit their official website at www.elanco.com.

About Elanco Animal Health

Elanco Animal Health is a global leader dedicated to enhancing animal health through innovative products and services. Its commitment to creating a positive impact spans beyond the immediate health of animals to encompass broader societal goals, including sustainable farming and improved welfare standards. This approach not only benefits the animals under care but also strengthens the relationships between farmers, pet owners, and the community at large.

Through strategic collaborations and a focus on next-generation solutions, Elanco is poised to continue its legacy of excellence in animal health for years to come.